Health
First patient fitted with Carmat artificial heart dies
Publish Date: Mar 04, 2014
First patient fitted with Carmat artificial heart dies
  • mail
  • img
newvision

The first patient fitted with an artificial heart made by the French company Carmat has died, the hospital that had performed the transplant in December said on Monday.

The 76-year-old man died on Sunday, 75 days after the operation, the Georges Pompidou European Hospital in Paris said in a statement, adding that the cause of his death could not be known for sure at this stage.

When he was fitted with the device, the man was suffering from terminal heart failure, when the sick heart can no longer pump enough blood to sustain the body, and was said to have only a few weeks, or even days, to live.

Carmat's bioprosthetic device is designed to replace the real heart for as much as five years, mimicking nature's work using biological materials and sensors. It aims to help the thousands of patients who die each year while awaiting a donor, and reducing the side-effects associated with transplants.

"Carmat wishes to pay tribute to the courage and the pioneering role of this patient and his family, as well as the medical team's dedication," a company spokeswoman said.

She stressed that it was premature to draw any conclusions on Carmat's artificial heart at this stage.

Three more patients in France with terminal heart failure are due to be fitted with the device. The clinical trial will be considered a success if the patients survive with the implant for at least a month.

If it passes the test, Carmat has said it would fit the device into about 20 patients with less severe heart failure. Reuters

 

The statements, comments, or opinions expressed through the use of New Vision Online are those of their respective authors, who are solely responsible for them, and do not necessarily represent the views held by the staff and management of New Vision Online.

New Vision Online reserves the right to moderate, publish or delete a post without warning or consultation with the author.Find out why we moderate comments. For any questions please contact digital@newvision.co.ug

  • mail
  • img
blog comments powered by Disqus
Also In This Section
Cases of head and neck cancers ‘on the rise’
Cases of head and neck cancers are on the rise at the Uganda cancer Institute (UCI), according to a medical expert....
HIV infections in Kasese not receding
The rate of HIV infections in Kasese district is not receding especially in the urban centres and the fishing villages, says the area secretary for social services....
Crackdown sees illegal drugs operators arrested
In a bid to curb drug thefts and misuse, the National Drug Authority (NDA) carried out an operation in parts of the city during which various drugs were impounded....
WHO prequalifies improved malaria treatment
The global health body prequalifies a new malaria treatment that will significantly reduce the number of tablets per dose....
Doctors raise concern about chemo for end-stage cancer
Giving chemotherapy terminal cancer patients nearing the end of their lives is likely to cause more harm than good....
Eye gives hope for cataract cure
An eye tested on dogs says cataracts, which causes blindness in humans, could one day be cured without surgery....
Should faith based organisations be registered as Non-government organisations?
Yes
No
Can't Say
follow us
subscribe to our news letter